Grifols · 9 hours ago
Intern - Global HEOR
Grifols is a global healthcare company that has been working to improve the health and well-being of people since 1909. The Global HEOR/RWE Intern will gain knowledge and proficiency in Global Health Economics and Outcomes Research while supporting various projects within the biopharmaceutical industry.
BiotechnologyHealth CareManufacturing
Responsibilities
Working with GHEOR researchers on typical HEOR & RWE studies within the Biopharmaceutical industry aligned with commercial and clinical stakeholders within the company
Supporting current projects and learn to design, manage, and report on those and new studies
Assisting internal teams (e.g., marketing, managed markets, market access, medical affairs, clinical development) to support HEOR/RWE research, and pharmacoeconomic initiatives
Supporting HEOR and RWE projects that may lead to abstracts/manuscripts for peer-reviewed publications
Qualification
Required
Candidate must be currently enrolled a graduate program (PharmD, MD, PhD, MPH, or related life sciences field)
Candidate must currently have GPA of 3.0 or higher
Excellent written and verbal communication skills
Ability to analyze scientific data and interpret medical literature
Proficiency in Microsoft Office (Excel, PowerPoint, Word)
Detail-oriented, organized, and able to manage multiple tasks in a fast-paced environment
Company
Grifols
Grifols is a global healthcare company.
H1B Sponsorship
Grifols has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2023 (2)
2022 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.51BKey Investors
Michael J. Fox Foundation
2025-01-14Grant· $21M
2024-06-04Post Ipo Debt· $1.41B
2024-04-23Post Ipo Debt· $1.07B
Leadership Team
Recent News
2025-12-24
Pharma Letter
2025-11-28
Company data provided by crunchbase